PrEP Works in Injection-Drug Users — CDC Offers “Guidance”

Jun 17, 2013

June 17, 2013

Topics

New CDC guidance on PrEP for injection-drug users is a welcome addition to the HIV prevention effort, says Dr. Paul Sax in his HIV and ID Observations blog.

In parallel with publication of a related study in The Lancet, the CDC has issued an update of its “Interim Guidance” on tenofovir pre-exposure prophylaxis, now focusing on injection-drug users. In his HIV and ID Observations blog, Dr. Paul Sax outlines the key aspects of the recommendation and explains why he thinks they make sense.